2.58
price down icon3.01%   -0.08
after-market アフターアワーズ: 2.56 -0.02 -0.78%
loading
前日終値:
$2.66
開ける:
$2.66
24時間の取引高:
43,114
Relative Volume:
0.05
時価総額:
$3.79M
収益:
$502.40K
当期純損益:
$-7.91M
株価収益率:
-0.2587
EPS:
-9.972
ネットキャッシュフロー:
$-4.32M
1週間 パフォーマンス:
+28.36%
1か月 パフォーマンス:
+1.18%
6か月 パフォーマンス:
-51.32%
1年 パフォーマンス:
-85.16%
1日の値動き範囲:
Value
$2.5475
$2.6731
1週間の範囲:
Value
$2.0298
$2.74
52週間の値動き範囲:
Value
$1.41
$35.99

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
名前
60 Degrees Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
202-327-5422
Name
住所
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
職員
3
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
SXTP's Discussions on Twitter

SXTP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
2.58 2.96M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

60 Degrees Pharmaceuticals Inc (SXTP) 最新ニュース

pulisher
May 27, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World

May 27, 2025
pulisher
May 27, 2025

Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World

May 27, 2025
pulisher
May 27, 2025

Weiss Ratings Reiterates Sell (D-) Rating for 180 Degree Capital (NASDAQ:TURN) - Defense World

May 27, 2025
pulisher
May 25, 2025

Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida

May 25, 2025
pulisher
May 19, 2025

Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

May 19, 2025
pulisher
May 16, 2025

VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines - Quantisnow

May 16, 2025
pulisher
May 15, 2025

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation - The Manila Times

May 15, 2025
pulisher
May 15, 2025

60 Degrees Pharmaceuticals, Inc. Reports 55% Increase in Q1 2025 Net Product Revenues to $163.6 Thousand - Nasdaq

May 15, 2025
pulisher
May 15, 2025

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

60 DEGREES PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 14, 2025

AST SpaceMobile (ASTS) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

60 Degrees Pharmaceuticals (SXTP) to Release Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

KORE Group (KORE) to Release Quarterly Earnings on Thursday - Defense World

May 14, 2025
pulisher
May 14, 2025

SPAR Group (SGRP) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Society Pass (SOPA) Projected to Post Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Windtree Therapeutics (WINT) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Spero Therapeutics (SPRO) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 11, 2025

60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World

May 11, 2025
pulisher
May 11, 2025

Spartan Delta Corp. (TSE:SDE) Given Average Recommendation of “Strong Buy” by Analysts - Defense World

May 11, 2025
pulisher
May 11, 2025

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

May 11, 2025
pulisher
May 11, 2025

National Bank Financial Weighs in on TSE:ATD FY2025 Earnings - Defense World

May 11, 2025
pulisher
May 11, 2025

FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald - Defense World

May 11, 2025
pulisher
May 11, 2025

Evoke Pharma (EVOK) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 11, 2025

Legend Biotech (LEGN) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 11, 2025

Best Green Energy Stocks To Research – May 9th - Defense World

May 11, 2025
pulisher
May 10, 2025

PTC Therapeutics (NASDAQ:PTCT) Raised to Strong-Buy at StockNews.com - Defense World

May 10, 2025
pulisher
May 10, 2025

Denny’s Co. (NASDAQ:DENN) Shares Sold by Barclays PLC - Defense World

May 10, 2025
pulisher
May 10, 2025

Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $83.25 - Defense World

May 10, 2025
pulisher
May 08, 2025

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq

May 08, 2025
pulisher
May 06, 2025

Raymond James Financial Inc. Makes New Investment in NETSTREIT Corp. (NYSE:NTST) - Defense World

May 06, 2025
pulisher
Apr 30, 2025

60 Degrees Pharmaceuticals Announces 2024 Annual Results - ADVFN

Apr 30, 2025
pulisher
Apr 25, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Sell (E+)” Rating at Weiss Ratings - Defense World

Apr 25, 2025
pulisher
Apr 23, 2025

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - ADVFN

Apr 23, 2025
pulisher
Apr 23, 2025

60 Degrees Pharmaceuticals (SXTP) Unveils Discrepancies in Babes - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

60 Degrees Pharmaceuticals Inc (SXTP) Stock: A Comprehensive 52-Week Review - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 23, 2025
pulisher
Apr 22, 2025

How is SXTP’s stock performing after recent trades? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Shocking Gap: Survey Finds 3 Million Babesiosis Cases While CDC Reports Only 1,834Major Market Opportunity - Stock Titan

Apr 22, 2025
pulisher
Apr 22, 2025

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey - Yahoo Finance

Apr 22, 2025
pulisher
Apr 21, 2025

Form 8-KCurrent report - ADVFN

Apr 21, 2025
pulisher
Apr 20, 2025

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - ADVFN

Apr 20, 2025
pulisher
Apr 17, 2025

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Short Interest Down 43.2% in March - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Deal Watch: Oak Hill Picks Up Where Roche Left Off In Angelman Syndrome - insights.citeline.com

Apr 15, 2025
pulisher
Apr 10, 2025

Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday? - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

60 Degrees Pharma's Breakthrough: New Clinical Trials Target Rising Tick-Borne Disease Crisis - Stock Titan

Apr 10, 2025
pulisher
Apr 09, 2025

10 Stocks Fall Behind Amid Market Optimism - Insider Monkey

Apr 09, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

Apr 09, 2025
pulisher
Apr 09, 2025

60 Degrees and Yale to progress tafenoquin for babesiosis - Yahoo

Apr 09, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025

60 Degrees Pharmaceuticals Inc (SXTP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):